Transition metal-free addition of dithiocarbamates to alkynes
525
(Z)-3-(Naphthalen-2-yloxy)prop-1-en-1-yl
J = 7.0 Hz, 2H), 3.78 (q, J = 7.0 Hz, 2H), 1.34 (t,
J = 7.0 Hz, 3H), 1.29 (t, J = 7.0 Hz, 3H) ppm; 13C
NMR (125 MHz, CDCl3): d = 190.8, 161.8, 161.4, 156.1,
143.8, 129.3, 127.9, 125.5, 113.6, 113.3, 113.2, 102.2,
66.4, 50.2, 47.6, 13.1, 11.9 ppm.
diethylcarbamodithioate (3j, C18H21NOS2)
Isolated by column chromatography. Rf = 0.64 (EtOAc/
petroleum ether, 1:4); 1H NMR (500 MHz, CDCl3):
d = 7.73–7.77 (m, 3H), 7.47 (t, J = 7.1 Hz, 1H),
7.32–7.37 (m, 2H), 7.16–7.21 (m, 2H), 6.24 (dt,
J = 10.0, 5.9 Hz, 1H), 4.78 (dd, J = 4.7, 1.1 Hz, 2H),
4.02 (t, J = 7.0 Hz, 2H), 3.73 (t, J = 7.0 Hz, 2H),
1.27–1.32 (m, 6H) ppm; 13C NMR (125 MHz, CDCl3):
d = 191.3, 156.7, 134.9, 129.9, 129.5, 128.1, 127.3, 127.1,
126.9, 126.8, 124.2, 119.3, 107.5, 66.1, 50.1, 47.6, 13.2,
12.0 ppm.
(Z)-3-[(2-Oxo-2H-chromen-6-yl)oxy]prop-1-en-1-yl piper-
idine-1-carbodithioate (3o, C18H19NO3S2)
Isolated by column chromatography. Rf = 0.31 (EtOAc/
petroleum ether, 1:2); 1H NMR (500 MHz, CDCl3):
d = 7.67 (d, J = 10.0 Hz, 1H), 7.41 (s, 1H), 7.31 (m, 1H),
6.81–6.85 (m, 2H), 6.27 (m, 1H), 6.11 (dt, J = 10.0, 5.9 Hz,
1H), 4.70 (d, J = 5.2 Hz, 2H), 3.98 (t, J = 6.7 Hz, 2H), 3.76
(t, J = 6.7 Hz, 2H), 1.73 (m, 6H) ppm; 13C NMR (125 MHz,
CDCl3): d = 190.8, 161.8, 156.2, 143.7, 129.2, 127.7, 125.8,
113.6, 113.4, 102.5, 66.4, 60.7, 56.6, 24.6, 21.4, 14.6 ppm.
(Z)-3-(Naphthalen-2-yloxy)prop-1-en-1-yl piperidine-1-
carbodithioate (3k, C19H21NOS2)
Isolated by column chromatography. Rf = 0.58 (EtOAc/
petroleum ether, 1:4); 1H NMR (500 MHz, CDCl3):
d = 7.77–7.81 (m, 3H), 7.48 (m, 1H), 7.35–7.40 (m, 2H),
7.18–7.23 (m, 2H), 6.28 (dt, J = 11.7, 5.8 Hz, 1H), 4.83
(dd, J = 6.1, 1.5 Hz, 2H), 4.34 (m, 2H), 3.93 (m, 2H), 1.74
(m, 6H) ppm; 13C NMR (125 MHz, CDCl3): d = 191.4,
156.7, 134.9, 129.9, 129.5, 128.1, 127.4, 127.1, 126.8,
124.5, 119.3, 107.5, 66.0, 56.3, 53.2, 26.6, 25.9, 24.6 ppm.
(Z)-3-Hydroxyprop-1-en-1-yl pyrrolidine-1-carbodithioate
(3p, C8H13NOS2)
Isolated by column chromatography. Rf = 0.30 (EtOAc/
petroleum ether, 1:2); 1H NMR (500 MHz, CDCl3):
d = 6.97 (d, J = 9.8, 1H), 6.02 (m, 1H), 4.56 (m, 2H),
3.94 (t, J = 7.0 Hz, 2H), 3.69 (t, J = 7.0 Hz, 2H), 2.2 (m,
4H) ppm; 13C NMR (125 MHz, CDCl3): d = 192.1, 166.0,
124.7, 60.8, 55.0, 52.0, 25.1, 23.2 ppm.
(Z)-3-(Naphthalen-2-yloxy)prop-1-en-1-yl azepane-1-
carbodithioate (3l, C20H23NOS2)
(Z)-Prop-1-ene-1,3-diyl bis(piperidine-1-carbodithioate)
(3q, C15H24N2S4)
Isolated by column chromatography. Rf = 0.69 (EtOAc/
petroleum ether, 1:4); 1H NMR (500 MHz, CDCl3):
d = 7.72–7.77 (m, 3H), 7.43 (m, 1H), 7.30–7.35 (m, 2H),
7.13–7.17 (m, 2H), 6.22 (dt, J = 9.9, 5.8 Hz, 1H), 4.78 (m,
2H), 4.20 (t, J = 6.0 Hz, 2H), 3.91 (t, J = 6.0 Hz, 2H),
1.87–1.89 (m, 2H), 1.58–1.61 (m, 6H) ppm; 13C NMR
(125 MHz, CDCl3): d = 192.2, 156.7, 134.9, 129.9, 129.5,
128.0, 127.2, 126.8, 124.1, 119.3, 107.4, 66.0, 56.1, 53.5,
28.3, 27.9, 26.9, 26.5 ppm.
Isolated by column chromatography. Rf = 0.22 (EtOAc/
petroleum ether, 1:3); 1H NMR (500 MHz, CDCl3):
d = 6.07 (m, 1H), 5.65 (m, 1H), 4.51 (m, 2H), 4.06 (m,
4H), 3.87 (m, 4H), 1.67 (m, 12H) ppm; 13C NMR
(125 MHz, CDCl3): d = 195.3, 193.8, 137.5, 130.8, 59.6,
52.8, 44, 26.5, 25.8, 24.6, 24.5 ppm.
Acknowledgments We are grateful to the Research Council of
Sharif University of Technology for financial support.
(Z)-3-[(2-Oxo-2H-chromen-6-yl)oxy]prop-1-en-1-yl
diethylcarbamodithioate (3m, C17H17NO3S2)
Isolated by column chromatography. Rf = 0.72 (EtOAc/
petroleum ether, 1:4); 1H NMR (500 MHz, CDCl3):
d = 7.65 (d, J = 9.9 Hz, 1H), 7.38 (s, 1H), 7.40 (m,
1H), 6.83–6.87 (m, 2H), 6.27 (m, 1H), 6.12 (dt, J = 9.9,
5.9 Hz, 1H), 4.70 (d, J = 5.1 Hz, 2H), 3.98 (t, J = 6.8 Hz,
2H), 3.76 (t, J = 6.8 Hz, 2H), 2.15 (m, 2H), 2.04 (m, 2H)
ppm; 13C NMR (125 MHz, CDCl3): d = 188.0, 161.0,
156.0, 143.7, 129.2, 127.7, 125.4, 113.7, 113.4, 102.5,
66.4, 55.6, 51.4, 26.4, 24.6 ppm.
References
1. Sheldon RA (2005) Green Chem 7:267
2. Ranu BC, Saha A, Dey R (2010) Curr Opin Drug Discov Dev
13:658
3. Tanaka K (2003) Solvent-free organic synthesis. Wiley, Germany
4. Tanaka K, Toda F (2000) Chem Rev 100:1025
5. Nagendrappa G (2002) Resonance 7:59
6. Zhou F, Ding M, Zhou J (2012) Org Biomol Chem 10:3178
7. Palisse A, Kirsch SF (2012) Org Biomol Chem 10:8041
´
8. Thome I, Bolm C (2012) Org Lett 14:1892
(Z)-3-[(2-oxo-2H-chromen-7-yl)oxy]prop-1-en-1-yl
diethylcarbamodithioate (3n, C17H19NO3S2)
White solid isolated by recrystallization from ethanol.
9. Thorn GD, Ludwig RA (1962) The dithiocarbamates and related
compounds. Elsevier, Amsterdam
10. Saha A, Nasir Baig RB, Leazer J, Varma RS (2012) Chem
Commun 48:8889
11. Das P, Kumar CK, Kumar KN, Innus M, Iqbal J, Srinivas N
(2008) Tetrahedron Lett 49:992
12. Ziyaei-Halimehjani A, Marjani K, Ashouri A (2012) Tetrahedron
Lett 53:3490
1
M.p.: 115 °C; H NMR (500 MHz, CDCl3): d = 7.62 (d,
J = 9.4 Hz, 1H), 7.35 (d, J = 8.5 Hz, 1H), 7.30 (d,
J = 8.7 Hz, 1H), 6.82 (m, 2H), 6.23 (d, J = 9.4 Hz, 1H),
6.11 (m, 1H), 4.70 (dd, J = 5.9, 1.3 Hz, 2H), 4.04 (q,
123